Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperkinesis

• Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
• Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
• Lisdexamphetamine vs Methylphenidate for Pediatric Patients With ADHD and Type 1 Diabetes
• Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
• An Open-Label Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
• Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
• An Efficacy and Safety Study w/ Azstarys® in Children With ADHD
• Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
• The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD
• A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
• A Phase 3 Efficacy and Safety in Pediatrics (6-17) With Attention-Deficit/Hyperactivity Disorder (ADHD) Using CTx-1301 (Dexmethylphenidate)
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
• A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder
• A Phase II Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD), Part II
• The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD
• Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder
• A Controlled Study of Solriamfetol for ADHD in Adults
• HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Advanced Cancer Patients; A Multi-Centre, Randomised-Controlled Trial
• Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD
• A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
• Evaluation of SPN-812 in Preschool-age Children With ADHD
• Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD
• Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
• Clinical Trial of Efficacy and Safety of Prospecta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
• Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
• Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
• A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder
• The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial
• Melatonin in ADHD and Sleep Problems
• Minimizing Pain During Office Intradetrussor Botox Injection
• Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder
• Real World Evidence of the Efficacy and Safety of FOQUEST
• Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
• A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
• Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
• Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
• Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening
• The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
• Acute Effects of Stimulant Medication in College Students With ADHD
• COMT Inhibition Among Individuals With Comorbid AUD/ADHD
• Tolperisone in Acute Muscle Spasm of the Back
• OT and Social Cognition in Children With ADHD: Impact of MPH
• Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
• Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
• Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
• Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
• PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
• A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
• A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
• A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
• Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD)
• A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
• Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
• A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD
• Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
• Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome
• Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD
• Added Value of the Oculomotor and Cognitive Examination in the Management of Patients With ADHD
• Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
• Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
• The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
• PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
• Long-term Effects of Medication for ADHD
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
• Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response
• Oxytocin and Cognitive Control in Adult ADHD
• Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
• Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
• A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD
• Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD
• A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects
• Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses
• Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Early Interventions in Children With Attention Deficit/Hyperactivity Disorder
• Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder
• Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
• The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
• Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder
• Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder
• Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder
• Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
• Concerta (Methylphenidate) -To-Generic Switch Study
• The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
• A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
• ERP Based Single-dose Predictions of Stimulants
• A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD
• A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
• Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
• Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHD
• Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
• Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
• Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
• Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
• Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder
• L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD
• Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• PK/PD Pediatric ADHD Classroom Study
• A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting
• A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting
• EAA/Therapy for Treating Children With ADHD
• The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
• Dasotraline Pediatric Extension Study
• Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD
• Dasotraline Pediatric ADHD Study
• Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder
• Neuroendocrine Substrates, Candidate Genes and Endophenotypes in ADHD
• Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
• Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
• Investigating the Effect of Vortioxetine in Adult ADHD Patients
• Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
• Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
• Dasotraline Adult ADHD Study
• An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
• A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
• Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
• Experimental Medicine in ADHD - Cannabinoids
• Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder
• Omega-3 Supplementation to ADHD Medication in Children
• Dasotraline SEP360-105 Pediatric PK/PD Study
• CBT Group for Adolescents With ADHD: a Randomized Controlled Trial
• Lisdexamfetamine's Effect In ADHD in the Brain and Cognition
• Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
• Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
• Open-label Safety Study in Adults With ADHD
• Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• ADHD Medication and Predictors of Treatment Outcome
• Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
• A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD
• TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD
• A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )
• Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))
• Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
• Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
• Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
• A Study of Combination Therapy in Children With ADHD
• A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants
• Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder
• Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
• A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
• An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
• L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults
• NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
• An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
• Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder
• The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
• Effect of Methylphenidate on Connectivity
• Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD)
• A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
• Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
• Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
• Adult Attention Deficit Hyperactivity Disorder
• Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
• Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD
• NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
• The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
• Botulinum Toxin for Pelvic Pain in Women With Endometriosis
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
• Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)
• Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe
• Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)
• A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD
• Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties
• A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
• A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
• Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)
• Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
• Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
• Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
• DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
• Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults
• Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
• Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
• Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
• Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
• Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
• Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil
• Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD
• A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
• Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
• Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine
• Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
• A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents
• Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
• Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
• Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
• Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
• Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
• Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
• Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
• Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
• Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
• An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
• The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults
• Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity
• An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
• Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• Juvenile Bipolar Disorder Outpatient Program
• Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
• Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects
• Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD
• Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
• A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
• A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
• Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
• Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
• Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine
• Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Bupropion for ADHD in Adolescents With Substance Use Disorder
• Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate
• Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia
• The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
• Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
• Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
• Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
• Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
• A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder
• Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)
• Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder
• International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder
• Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
• Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Atomoxetine, Placebo and Parent Management Training in Autism
• Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)
• Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder
• Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
• CONCERTA Lab School Study
• Lab School Day Study for CONCERTA of Older Children With ADHD
• Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
• A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
• Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD
• Neuroimaging of the Effects of Concerta in the Treatment of ADHD
• Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
• The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
• Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
• The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
• Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children
• Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults
• Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
• Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
• Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA
• Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
• Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia
• A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder
• A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
• Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
• Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood
• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
• Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD
• Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
• Study of Medication Patch to Treat Children Ages 6-12 With ADHD
• Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
• Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse
• Enhancing ADHD Driving Performance With Stimulant Medication
• Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.
• The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
• A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.
• ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
• NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
• Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
• Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
• A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence
• Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms
• Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
• A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
• Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
• Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory
• A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
• A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder
• Methylphenidate Study in Young Children With Developmental Disorders
• Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
• Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
• Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
• Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD
• Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD
• Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
• A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
• Effects of Ritalin on Postural Stability of Hyper Active Children
• Safety Study in Outpatient Japanese Children With ADHD
• Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy
• Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD
• Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
• Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD)
• A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)
• A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
• Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder
• Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
• A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
• A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents
• Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
• A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
• Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
• Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
• A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
• Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder
• Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
• Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
• Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
• Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
• Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany
• Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
• Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
• A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
• Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
• The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting
• Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder
• Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison
• Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment
• An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
• A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
• Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
• Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
• Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
• Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
• An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
• Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL
• Effects of L-Theanine in Boys With ADHD
• Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
• Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder
• A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
• A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children
• An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
• Long-Duration Stimulant Treatment Study of ADHD in Young Children
• Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children
• An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
• Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
• An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm
• A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.
• CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
• Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
• Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
• Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
• Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
• Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
• Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
• Safety and Efficacy of SPD465 in Adults With ADHD
• An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).
• Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
• Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
• Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
• An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder
• Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
• Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents
• Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes
• Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents
• An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder
• Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
• Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
• Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD
• A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
• A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Long-Term, Open Label Atomoxetine Study
• Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
• Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
• Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
• Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
• Safety of SPD465 in Treating Adults With ADHD.
• Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.
• Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17
• Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
• Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
• Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials
• Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
• Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
• Efficacy and Safety of SPD465 in Adults With ADHD
• Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
• Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
• Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
• Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
• Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
• Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
• Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
• Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
• Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
• Treatment of Youth With ADHD and Anxiety
• Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)